Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine local infiltration with celecoxib and pregabalin for pain control after spinal surgery
ChiCTR2000031236Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine, celecoxib and pregabalin in postoperative pain (3 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoints: VAS of pain and PCA dose. Started Mar 2020; status: recruiting.
02
Drugs
ropivacainecelecoxibpregabalin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2000031236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031236.